Paion AG
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation… Read more
Paion AG (PAIOF) - Total Liabilities
Latest total liabilities as of June 2023: $35.30 Million USD
Based on the latest financial reports, Paion AG (PAIOF) has total liabilities worth $35.30 Million USD as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Paion AG - Total Liabilities Trend (2003–2022)
This chart illustrates how Paion AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Paion AG Competitors by Total Liabilities
The table below lists competitors of Paion AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kayne Anderson BDC, Inc.
NYSE:KBDC
|
USA | $1.18 Billion |
|
Piovan SpA
STU:PV0
|
Germany | €330.76 Million |
|
MAIRE TECNIMONT
BE:3OY1
|
Germany | €6.07 Billion |
|
KYOCERA (KYR.SG)
STU:KYR
|
Germany | €1.21 Trillion |
|
Insimbi Refractory Alloy Supply
JSE:ISB
|
South Africa | ZAC817.19 Million |
|
SIG Group AG
STU:1YQA
|
Germany | €4.44 Billion |
|
DT REAL ESTATE
MU:DRE2
|
Germany | €115.56 Million |
Liability Composition Analysis (2003–2022)
This chart breaks down Paion AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -11.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Paion AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Paion AG (2003–2022)
The table below shows the annual total liabilities of Paion AG from 2003 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $31.56 Million | +5.96% |
| 2021-12-31 | $29.79 Million | +334.19% |
| 2020-12-31 | $6.86 Million | -32.61% |
| 2019-12-31 | $10.18 Million | +190.72% |
| 2018-12-31 | $3.50 Million | -47.40% |
| 2017-12-31 | $6.66 Million | -48.96% |
| 2016-12-31 | $13.04 Million | +64.94% |
| 2015-12-31 | $7.91 Million | +100.61% |
| 2014-12-31 | $3.94 Million | -15.91% |
| 2013-12-31 | $4.69 Million | -63.28% |
| 2012-12-31 | $12.76 Million | -2.34% |
| 2011-12-31 | $13.07 Million | -12.09% |
| 2010-12-31 | $14.87 Million | -8.48% |
| 2009-12-31 | $16.25 Million | -8.66% |
| 2008-12-31 | $17.79 Million | +613.18% |
| 2007-12-31 | $2.49 Million | -81.39% |
| 2005-12-31 | $13.40 Million | +29.39% |
| 2004-12-31 | $10.36 Million | +327.40% |
| 2003-12-31 | $2.42 Million | -- |